Spero Therapeutics


Spero Therapeutics (Nasdaq: SPRO) is a multi-asset pre-commercial stage biopharmaceutical company in Cambridge, Mass. We are highly committed to advancing novel treatment approaches for bacterial infections with a world-class team of biotechnological and biopharmaceutical experts. The company has a... Read more






Org chart

Sath Shukla
President & CEO

Sath Shukla

Esther Rajavelu
CFO & Chief Business Officer
Cristina Larkin
Chief Operating Officer
Tamara Joseph
Chief Legal Officer
Kamal Hamed
Chief Medical Officer
Timothy Keutzer
Chief Development Officer
Jamie Brady
Chief Human Resources Officer
Thomas Parr
Chief Scientific Officer
David Musselman
SVP, Sales & Market Access
Jay Blackington
VP, People Strategy & Culture
Melissa Stundick
VP, Business Development
Michael Pucci
Executive Director, Early Drug Discovery
Terese Hoekstra
VP, Market Access
Akash Jain
VP, Alliance Management & Business Development
Ed Sopp
VP & Head, Quality Assurance
Susan Redican
VP & Head, Clinical Operations
Kathy Burke
Executive Director & Head Market Access
Shekman Wong
Executive Director & Head, Clinical Pharmacology DMPK & Drug Analysis
Nivedita Bhatt
Senior Director
Indu Lakhani
Director Biostatistics Statistical Programming
Hanna Kwak
Ilia Terova
Director CMC
Myriah Satterfield
Associate Director, Clinical Data Mangement
Laura McGinn
Senior Executive Assistant